Akoya Biosciences(us:AKYA)
1.35
-2.88%
Updated on 2025-04-02
Open:1.42
Close:1.35
High:1.49
Low:1.34
Prev Close:1.39
Volume:200327.00
Turnover:278950.66
Turnover Ratio:0.40%
Shares:49.82M
MarketCap:67.25M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 73 | 12371024 | 25.01% | 6 | 21 | 35 |
| 2024-03-31 | 75 | 14854380 | 30.11% | 12 | 17 | 30 |
| 2023-12-31 | 73 | 14757127 | 30.04% | 10 | 25 | 29 |
| 2023-09-30 | 77 | 16068068 | 32.75% | 6 | 32 | 27 |
| 2023-06-30 | 81 | 16380861 | 33.55% | 20 | 31 | 22 |
| 2023-03-31 | 77 | 13346363 | 34.76% | 6 | 25 | 37 |
| 2022-12-31 | 79 | 14069014 | 36.74% | 20 | 20 | 26 |
| 2022-09-30 | 64 | 14383446 | 37.90% | 10 | 23 | 20 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Blue Water Life Science Advisors, Lp | 4697785 | 9.52% | 0 | |
| 2024-03-31 | Polar Capital Holdings Plc | 1579756 | 3.20% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 1454288 | 2.95% | 46131 | 3.28% |
| 2024-03-31 | Blackrock Inc. | 1347539 | 2.73% | -24693 | -1.80% |
| 2024-03-31 | Parkman Healthcare Partners Llc | 917442 | 1.86% | 242655 | 35.96% |
| 2024-03-31 | Uniplan Investment Counsel, Inc. | 699837 | 1.42% | 26314 | 3.91% |
| 2024-03-31 | Silvercrest Asset Management Group Llc | 580834 | 1.18% | 580834 | |
| 2024-03-31 | Svb Wealth Llc | 515317 | 1.04% | 0 | |
| 2024-03-31 | Geode Capital Management, Llc | 514049 | 1.04% | 15874 | 3.19% |
| 2024-03-31 | State Street Corp | 428327 | 0.87% | 70736 | 19.78% |
About
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Address:100 Campus Drive,6th Floor
Website:http://www.akoyabio.com
Market Movers